2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Colitis, Ulcerative
3
Urogenital Neoplasms
2
Inflammatory Bowel Diseases
2
Crohn Disease
2
Colitis
2
Carcinoma, Non-Small-Cell Lung
2
Takayasu Arteritis
1
Recurrence
1
Melanoma
1
Lung Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Data Collection
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Blood Specimen Collection
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
human papillomavirus vaccine, L1 type 16, 18
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
apremilast
1
Watchful Waiting
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Autoimmune Diseases
×
CT-P13
×
Clear all
NCT03348046
2020-03-04
PASSRRA
Hikma Pharmaceuticals LLC
Completed
22 enrolled